SK67699A3 - Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases - Google Patents
Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases Download PDFInfo
- Publication number
- SK67699A3 SK67699A3 SK676-99A SK67699A SK67699A3 SK 67699 A3 SK67699 A3 SK 67699A3 SK 67699 A SK67699 A SK 67699A SK 67699 A3 SK67699 A3 SK 67699A3
- Authority
- SK
- Slovakia
- Prior art keywords
- carbon atoms
- group
- formula
- straight
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19649460A DE19649460A1 (de) | 1996-11-26 | 1996-11-26 | Neue substituierte Pyrazolderivate |
PCT/EP1997/006366 WO1998023619A1 (de) | 1996-11-26 | 1997-11-14 | Neue substituierte pyrazolderivate zur behandlung von herzkreislauferkrankungen |
Publications (1)
Publication Number | Publication Date |
---|---|
SK67699A3 true SK67699A3 (en) | 2000-02-14 |
Family
ID=7813100
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK676-99A SK67699A3 (en) | 1996-11-26 | 1997-11-14 | Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP0944631B1 (xx) |
JP (2) | JP4422800B2 (xx) |
CN (1) | CN1122032C (xx) |
AR (1) | AR010310A1 (xx) |
AT (1) | ATE259812T1 (xx) |
AU (1) | AU729642B2 (xx) |
BR (1) | BR9714363A (xx) |
CA (1) | CA2272584C (xx) |
CZ (1) | CZ185099A3 (xx) |
DE (2) | DE19649460A1 (xx) |
DK (1) | DK0944631T3 (xx) |
EE (1) | EE9900211A (xx) |
ES (1) | ES2214646T3 (xx) |
HK (1) | HK1023119A1 (xx) |
HU (1) | HUP0000562A3 (xx) |
ID (1) | ID21881A (xx) |
IL (1) | IL129998A0 (xx) |
MX (1) | MXPA99004826A (xx) |
NO (1) | NO992400D0 (xx) |
NZ (1) | NZ335890A (xx) |
PT (1) | PT944631E (xx) |
SK (1) | SK67699A3 (xx) |
TR (1) | TR199901172T2 (xx) |
TW (1) | TW403746B (xx) |
WO (1) | WO1998023619A1 (xx) |
ZA (1) | ZA9710573B (xx) |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19744026A1 (de) * | 1997-10-06 | 1999-04-08 | Hoechst Marion Roussel De Gmbh | Pyrazol-Derivate, ihre Herstellung und ihre Verwendung in Arzneimitteln |
DE19827679A1 (de) * | 1998-06-22 | 1999-12-23 | Dresden Arzneimittel | Adenosinrezeptoraffine, antikonvulsiv und antiallergisch/antiasthmatisch wirkende Pyrazolo[3,4-d]pyrimidine und Verfahren zu deren Herstellung |
DE19834047A1 (de) * | 1998-07-29 | 2000-02-03 | Bayer Ag | Substituierte Pyrazolderivate |
DE19834044A1 (de) * | 1998-07-29 | 2000-02-03 | Bayer Ag | Neue substituierte Pyrazolderivate |
DE19834045A1 (de) * | 1998-07-29 | 2000-02-03 | Bayer Ag | (4-Amino-5-ethylpyrimidin-2-yl)-1-(2-fluorbenzyl)-1H-pyrazolo[3,4-b]pyridin |
GB9824310D0 (en) * | 1998-11-05 | 1998-12-30 | Univ London | Activators of soluble guanylate cyclase |
DE19920352A1 (de) * | 1999-05-04 | 2000-11-09 | Bayer Ag | Substituiertes Pyrazolderivat |
DE19943636A1 (de) | 1999-09-13 | 2001-03-15 | Bayer Ag | Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften |
DE19943634A1 (de) | 1999-09-13 | 2001-04-12 | Bayer Ag | Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften |
DE19943635A1 (de) * | 1999-09-13 | 2001-03-15 | Bayer Ag | Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften |
DE10021069A1 (de) * | 2000-04-28 | 2001-10-31 | Bayer Ag | Substituiertes Pyrazolderivat |
DE10057754A1 (de) | 2000-11-22 | 2002-05-23 | Bayer Ag | Neue Sulfonamid-substituierte Pyrazolopyridinderivate |
CA2429308C (en) | 2000-11-22 | 2010-09-21 | Bayer Aktiengesellschaft | Novel lactam-substituted pyrazolopyridine derivatives |
AR031176A1 (es) | 2000-11-22 | 2003-09-10 | Bayer Ag | Nuevos derivados de pirazolpiridina sustituidos con piridina |
DE10057751A1 (de) | 2000-11-22 | 2002-05-23 | Bayer Ag | Neue Carbamat-substituierte Pyrazolopyridinderivate |
DE10109858A1 (de) | 2001-03-01 | 2002-09-05 | Bayer Ag | Neuartige halogensubstituierte Aminodicarbonsäurederivate |
DE10109861A1 (de) | 2001-03-01 | 2002-09-05 | Bayer Ag | Neuartige seitenkettenhalogenierte Aminodicarbonsäurederivate |
DE10110749A1 (de) * | 2001-03-07 | 2002-09-12 | Bayer Ag | Substituierte Aminodicarbonsäurederivate |
DE10122894A1 (de) | 2001-05-11 | 2002-11-14 | Bayer Ag | Neue Sulfonat-substituierte Pyrazolopyridinderivate |
DE10132416A1 (de) * | 2001-07-04 | 2003-01-16 | Bayer Ag | Neue Morpholin-überbrückte Pyrazolopyridinderivate |
DE10220570A1 (de) | 2002-05-08 | 2003-11-20 | Bayer Ag | Carbamat-substituierte Pyrazolopyridine |
DE10232572A1 (de) * | 2002-07-18 | 2004-02-05 | Bayer Ag | Neue 2,5-disubstituierte Pyrimidinderivate |
DE10244810A1 (de) | 2002-09-26 | 2004-04-08 | Bayer Ag | Neue Morpholin-überbrückte Indazolderivate |
US7226941B2 (en) * | 2003-06-30 | 2007-06-05 | Hif Bio, Inc. | Compound for treating angiogenesis |
DE102005050497A1 (de) | 2005-10-21 | 2007-04-26 | Bayer Healthcare Ag | Difluorphenol-Derivate und ihre Verwendung |
DE102005050498A1 (de) | 2005-10-21 | 2007-06-06 | Bayer Healthcare Aktiengesellschaft | Cyclopropylessigsäure-Derivate und ihre Verwendung |
DE102005050375A1 (de) | 2005-10-21 | 2007-04-26 | Bayer Healthcare Ag | Tetrazol-Derivate und ihre Verwendung |
DE102005050376A1 (de) | 2005-10-21 | 2007-05-31 | Bayer Healthcare Ag | Dicarbonsäure-Derivate und ihre Verwendung |
DE102005050377A1 (de) | 2005-10-21 | 2007-04-26 | Bayer Healthcare Ag | Heterocyclische Verbindungen und ihre Verwendung |
DE102006020327A1 (de) * | 2006-04-27 | 2007-12-27 | Bayer Healthcare Ag | Heterocyclisch substituierte, anellierte Pyrazol-Derivate und ihre Verwendung |
DE102006043443A1 (de) | 2006-09-15 | 2008-03-27 | Bayer Healthcare Ag | Neue aza-bicyclische Verbindungen und ihre Verwendung |
DE102007015034A1 (de) | 2007-03-29 | 2008-10-02 | Bayer Healthcare Ag | Lactam-substituierte Dicarbonsäuren und ihre Verwendung |
DE102007015035A1 (de) | 2007-03-29 | 2008-10-02 | Bayer Healthcare Ag | Substituierte Dibenzoesäure-Derivate und ihre Verwendung |
DE102007026392A1 (de) | 2007-06-06 | 2008-12-11 | Bayer Healthcare Ag | Lösungen für die Perfusion und Konservierung von Organen und Geweben |
DE102007028407A1 (de) | 2007-06-20 | 2008-12-24 | Bayer Healthcare Ag | Substituierte Oxazolidinone und ihre Verwendung |
DE102007028320A1 (de) | 2007-06-20 | 2008-12-24 | Bayer Healthcare Ag | Substituierte Oxazolidinone und ihre Verwendung |
DE102007028406A1 (de) | 2007-06-20 | 2008-12-24 | Bayer Healthcare Ag | Substituierte Oxazolidinone und ihre Verwendung |
DE102007028319A1 (de) | 2007-06-20 | 2008-12-24 | Bayer Healthcare Ag | Substituierte Oxazolidinone und ihre Verwendung |
PL2294066T3 (pl) | 2008-04-28 | 2015-02-27 | Janssen Pharmaceutica Nv | Benzimidazole jako inhibitory hydroksylazy prolilowej |
EP2138178A1 (en) | 2008-06-28 | 2009-12-30 | Bayer Schering Pharma Aktiengesellschaft | Oxazolidninones for the treatment fo chronic obstructive pulmonary disease (COPD) and/or asthma |
DE102008063992A1 (de) | 2008-12-19 | 2010-09-02 | Lerner, Zinoviy, Dipl.-Ing. | Neue aliphatisch substituierte Pyrazolopyridine und ihre Verwendung |
DE102009004245A1 (de) | 2009-01-09 | 2010-07-15 | Bayer Schering Pharma Aktiengesellschaft | Neue anellierte, Heteroatom-verbrückte Pyrazol- und Imidazol-Derivate und ihre Verwendung |
UY33041A (es) | 2009-11-27 | 2011-06-30 | Bayer Schering Pharma Aktienegesellschaft | Procedimiento para la preparaciòn de {4,6-diamino-2-[1-(2-fluorobencil)-1h-pirazolo[3,4-b]piridin-3-il]pirimidin-5-il}carbamato de metilo y su purificaciòn para el uso como principio activo farmacèutico |
GB201004311D0 (en) | 2010-03-15 | 2010-04-28 | Proximagen Ltd | New enzyme inhibitor compounds |
CA2803292C (en) | 2010-06-30 | 2016-06-14 | Ironwood Pharmaceuticals, Inc. | Sgc stimulators |
NZ609955A (en) | 2010-11-09 | 2015-05-29 | Ironwood Pharmaceuticals Inc | Sgc stimulators |
JP6005134B2 (ja) * | 2011-04-21 | 2016-10-12 | バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH | フルオロアルキル置換ピラゾロピリジンおよびその使用 |
EP2755974A1 (en) | 2011-09-14 | 2014-07-23 | Proximagen Limited | New enzyme inhibitor compounds |
EP3112363A1 (en) | 2011-12-27 | 2017-01-04 | Ironwood Pharmaceuticals, Inc. | 2-[1-[(2-fluorophenyl)methyl]-5-(3-isoxazolyl)-1h-pyrazol-3-yl]-pyrimidine derivatives and related compounds as soluble guanylate cyclase (sgc) stimulators for the treatment of pulmonary hypertension |
ES2698950T3 (es) | 2012-05-10 | 2019-02-06 | Bayer Pharma AG | Anticuerpos capaces de unirse al Factor XI de coagulación y/o a su forma activada, Factor XIa, y usos de los mismos |
WO2015106268A1 (en) | 2014-01-13 | 2015-07-16 | Ironwood Pharmaceuticals, Inc. | USE OF sGC STIMULATORS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS |
KR20180002657A (ko) | 2015-05-06 | 2018-01-08 | 바이엘 파마 악티엔게젤샤프트 | 전신 경화증 (SSc)에 수반되는 수족지 궤양 (DU)의 치료를 위한 sGC 자극제, sGC 활성화제 단독 및 PDE5 억제제와의 조합물의 용도 |
FI3325013T4 (fi) | 2015-07-23 | 2023-10-11 | Liukoisen guanylaattisyklaasin (sgc) stimulaattoreita ja/tai aktivaattoreita yhdistelmänä neutraalin endopeptidaasin estäjän (nep-estäjä) ja/tai angiotensiini aii -antagonistin kanssa ja niiden käyttö | |
US20180344735A1 (en) | 2015-12-14 | 2018-12-06 | Ironwood Pharmaceuticals, Inc. | USE OF sGC STIMULATORS FOR THE TREATMENT OF GASTROINTESTINAL SPHINCTER DYSFUNCTION |
WO2017121700A1 (de) * | 2016-01-15 | 2017-07-20 | Bayer Pharma Aktiengesellschaft | 1,3-disubstituierte 1h-pyrazolo[3,4-b]pyridin- derivate und ihre verwendung als stimulatoren der löslichen guanylatcyclase |
WO2018069148A1 (de) | 2016-10-11 | 2018-04-19 | Bayer Pharma Aktiengesellschaft | Kombination enthaltend sgc aktivatoren und mineralocorticoid-rezeptor-antagonisten |
CA3039734A1 (en) | 2016-10-11 | 2018-04-19 | Bayer Pharma Aktiengesellschaft | Combination containing sgc stimulators and mineralocorticoid receptor antagonists |
US20190381039A1 (en) | 2016-12-13 | 2019-12-19 | Cyclerion Therapeutics, Inc. | USE OF sGC STIMULATORS FOR THE TREATMENT OF ESOPHAGEAL MOTILITY DISORDERS |
JP7090639B2 (ja) | 2017-04-11 | 2022-06-24 | サンシャイン・レイク・ファーマ・カンパニー・リミテッド | フッ素置換されたインダゾール化合物及びその使用 |
AU2019269047A1 (en) | 2018-05-15 | 2020-11-26 | Bayer Aktiengesellschaft | 1,3-thiazol-2-yl substituted benzamides for the treatment of diseases associated with nerve fiber sensitization |
SG11202100092QA (en) | 2018-07-11 | 2021-02-25 | Cyclerion Therapeutics Inc | USE OF sGC STIMULATORS FOR THE TREATMENT OF MITOCHONRIAL DISORDERS |
WO2020164008A1 (en) | 2019-02-13 | 2020-08-20 | Bayer Aktiengesellschaft | Process for the preparation of porous microparticles |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0615542B2 (ja) * | 1986-07-22 | 1994-03-02 | 吉富製薬株式会社 | ピラゾロピリジン化合物 |
US4994482A (en) * | 1989-07-31 | 1991-02-19 | Bristol-Myers Squibb Company | Arylpyrazol derivatives as anti-platelet agents, compositions and use |
EP0641564A4 (en) * | 1992-05-21 | 1995-05-03 | Yoshitomi Pharmaceutical | OPTICALLY ACTIVE CONDENSED PYRAZOLE COMPOUND FOR THE TREATMENT OF THROMBOCYTOPENIA AND ERYTHROPENIA. |
JP2928079B2 (ja) * | 1994-02-14 | 1999-07-28 | 永信薬品工業股▲ふん▼有限公司 | 1−(置換ベンジル)−3−(置換アリール)縮合ピラゾール類、その製造法及びその用途 |
CN1039536C (zh) * | 1994-02-28 | 1998-08-19 | 永信药品工业股份有限公司 | 1,3取代缩合吡唑类化合物及其应用和制备方法 |
-
1996
- 1996-11-26 DE DE19649460A patent/DE19649460A1/de not_active Withdrawn
-
1997
- 1997-11-14 BR BR9714363A patent/BR9714363A/pt active Search and Examination
- 1997-11-14 PT PT97951204T patent/PT944631E/pt unknown
- 1997-11-14 IL IL12999897A patent/IL129998A0/xx unknown
- 1997-11-14 HU HU0000562A patent/HUP0000562A3/hu unknown
- 1997-11-14 WO PCT/EP1997/006366 patent/WO1998023619A1/de not_active Application Discontinuation
- 1997-11-14 DK DK97951204T patent/DK0944631T3/da active
- 1997-11-14 JP JP52421898A patent/JP4422800B2/ja not_active Expired - Fee Related
- 1997-11-14 SK SK676-99A patent/SK67699A3/sk unknown
- 1997-11-14 ID IDW990388A patent/ID21881A/id unknown
- 1997-11-14 EP EP97951204A patent/EP0944631B1/de not_active Expired - Lifetime
- 1997-11-14 NZ NZ335890A patent/NZ335890A/en unknown
- 1997-11-14 AT AT97951204T patent/ATE259812T1/de active
- 1997-11-14 DE DE59711321T patent/DE59711321D1/de not_active Expired - Lifetime
- 1997-11-14 TR TR1999/01172T patent/TR199901172T2/xx unknown
- 1997-11-14 EE EEP199900211A patent/EE9900211A/xx unknown
- 1997-11-14 MX MXPA99004826A patent/MXPA99004826A/es not_active IP Right Cessation
- 1997-11-14 AU AU54823/98A patent/AU729642B2/en not_active Ceased
- 1997-11-14 ES ES97951204T patent/ES2214646T3/es not_active Expired - Lifetime
- 1997-11-14 CN CN97180065A patent/CN1122032C/zh not_active Expired - Fee Related
- 1997-11-14 CZ CZ991850A patent/CZ185099A3/cs unknown
- 1997-11-14 CA CA002272584A patent/CA2272584C/en not_active Expired - Fee Related
- 1997-11-21 TW TW086117406A patent/TW403746B/zh not_active IP Right Cessation
- 1997-11-25 ZA ZA9710573A patent/ZA9710573B/xx unknown
- 1997-11-26 AR ARP970105563A patent/AR010310A1/es active IP Right Grant
-
1999
- 1999-05-19 NO NO992400A patent/NO992400D0/no unknown
-
2000
- 2000-04-13 HK HK00102254A patent/HK1023119A1/xx not_active IP Right Cessation
-
2009
- 2009-09-11 JP JP2009210476A patent/JP2010013475A/ja not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
EP0944631B1 (de) | 2004-02-18 |
WO1998023619A1 (de) | 1998-06-04 |
NO992400L (no) | 1999-05-19 |
AR010310A1 (es) | 2000-06-07 |
CA2272584C (en) | 2007-10-16 |
NZ335890A (en) | 2001-02-23 |
HK1023119A1 (en) | 2000-09-01 |
HUP0000562A3 (en) | 2001-12-28 |
CN1122032C (zh) | 2003-09-24 |
CN1238773A (zh) | 1999-12-15 |
DE19649460A1 (de) | 1998-05-28 |
CZ185099A3 (cs) | 1999-08-11 |
HUP0000562A2 (hu) | 2000-10-28 |
JP4422800B2 (ja) | 2010-02-24 |
JP2001505567A (ja) | 2001-04-24 |
JP2010013475A (ja) | 2010-01-21 |
ES2214646T3 (es) | 2004-09-16 |
AU5482398A (en) | 1998-06-22 |
ATE259812T1 (de) | 2004-03-15 |
EE9900211A (et) | 1999-12-15 |
EP0944631A1 (de) | 1999-09-29 |
ID21881A (id) | 1999-08-05 |
TR199901172T2 (xx) | 1999-08-23 |
AU729642B2 (en) | 2001-02-08 |
IL129998A0 (en) | 2000-02-29 |
CA2272584A1 (en) | 1998-06-04 |
NO992400D0 (no) | 1999-05-19 |
PT944631E (pt) | 2004-06-30 |
DE59711321D1 (de) | 2004-03-25 |
TW403746B (en) | 2000-09-01 |
DK0944631T3 (da) | 2004-06-07 |
ZA9710573B (en) | 1998-06-10 |
BR9714363A (pt) | 2000-03-21 |
MXPA99004826A (es) | 2008-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK67699A3 (en) | Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases | |
US6451805B1 (en) | Substituted pyrazole derivatives for the treatment of cardiocirculatory diseases | |
US9045428B2 (en) | Substituted heterocyclic compounds | |
JP5501369B2 (ja) | 可溶性グアニレートシクラーゼ活性化剤 | |
JP4309653B2 (ja) | 新規なスルホンアミド置換ピラゾロピリジン誘導体 | |
JP4246991B2 (ja) | 新規なピリジン置換ピラゾロピリジン誘導体 | |
JP7191826B2 (ja) | 三環式rhoキナーゼ阻害剤 | |
JP2005501034A (ja) | モルホリン架橋のピラゾロピリジン誘導体 | |
SK1302001A3 (en) | SUBSTITUTED PYRAZOLE DERIVATIVES CONDENSED WITH SIX-MEMBEREDì (54) HETEROCYCLIC RINGS | |
JP2012509877A5 (xx) | ||
BG106568A (bg) | 5-(2-заместени-5-хетероциклилсулфонилпирид-3-ил)-дихидропиразоло[4,3-d]пиримидин-7-они като фосфодиестеразни инхибитори | |
SK16972002A3 (sk) | Beta-karbolínové deriváty použiteľné ako inhibítory fosfodiesterázy | |
WO2017162007A1 (zh) | 芳香族酰胺类衍生物、其制备方法及其在医药上的应用 | |
DE10021069A1 (de) | Substituiertes Pyrazolderivat | |
AU597190B2 (en) | Therapeutic agents | |
US20090181986A1 (en) | Substituted heterocyclic compounds | |
KR20060092219A (ko) | 유도성 no-합성효소 억제제로서의 아미노피리딘-유도체 | |
DE60319254T2 (de) | Pyrazolamide zur behandlung von hiv-infektionen | |
JP2001220390A (ja) | 縮合ピラゾール誘導体 | |
EP4194450A1 (en) | Cdk9 inhibitor and use thereof | |
CA2507958A1 (en) | Pyrazole compounds as integrin receptor antagonists derivatives | |
CZ2001333A3 (cs) | Substituované deriváty pyrazolu, způsob jejich výroby, léčiva tyto látky obsahující a jejich použití |